Microscopic view representing stem cell and exosome signaling
Core Therapy Guide

Combined Stem Cell + Exosome Protocols

A combined protocol brings cellular MSC therapy and cell-free exosome signaling into one medically reviewed plan.

Evidence for combined administration is still developing. We assess it case by case, explain alternatives, and never present it as automatically better than either therapy alone.

Stem Cells, Exosomes, or Both?

The right option depends on diagnosis, current treatment, medical history, goals, and the quality of available evidence.

Stem Cell Therapy

  • Whole mesenchymal stem cells
  • Cellular response to the tissue environment
  • IV and targeted delivery options

العلاج بالإكسوسومات

  • Cell-free signaling vesicles
  • Carries growth factors, cytokines, and microRNA
  • IV and condition-specific targeted options

Combined Protocol

  • Coordinates both components in one plan
  • Used only where medical review supports a rationale
  • Evidence remains limited and outcomes vary

Medical Review Comes First

The team reviews your diagnosis, records, imaging, current medicines, previous procedures, and treatment goals before discussing any protocol.

Who may benefit?

Limitations Stay Visible

Combined treatment is not suitable for everyone and does not replace standard specialist care. Active cancer, uncontrolled infection, and other safety exclusions require careful review.

Review safety and exclusions

Delivery Is Condition-Specific

MSCs and exosomes may be delivered intravenously or through targeted routes where appropriate. The written proposal states what is delivered, why, and in what sequence.

Explore by Condition Pillar

Start with the condition pillar that matches your main reason for seeking treatment, then review its treatment leaves and answers.

الأسئلة الشائعة

A combined protocol delivers mesenchymal stem cells (MSCs) together with MSC-derived exosome infusions in one coordinated treatment plan. The stem cells provide the cellular regenerative component, while exosomes deliver signaling cargo such as growth factors, cytokines, and microRNA in a cell-free form.

Exosomes are nano-sized vesicles released by mesenchymal stem cells that carry regenerative signals without transplanting cells themselves. Stem cell therapy delivers whole cells, while exosome therapy is a cell-free approach using their signaling molecules.

Yes. Some patients receive both therapies in a coordinated protocol. Medical records review determines whether a combined protocol is appropriate; it is not a default upgrade.

Evidence for combination protocols is still emerging. Individual MSC therapy and exosome therapy each have growing clinical literature, but head-to-head data on combined administration is limited. We discuss combined protocols case by case and do not guarantee outcomes.

A combined protocol may be considered when medical review identifies a rationale for both cellular and cell-free components. Suitability depends on the condition, medical history, goals, and safety screening.

Combined protocols are priced individually because their composition depends on the treatment plan. MSC packages start from €6,950; any exosome component is quoted after medical review. Packages include laboratory processing, hospital care, hotel, and transfers as specified in the proposal.

Get a Protocol Recommendation, Not a Sales Upgrade

Share your records for a no-obligation review. The recommendation may be stem cells, exosomes, a combined protocol, or no treatment.